Login / Signup

Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.

Sujha SubramanianRobai GakungaJoseph KibachioGladwell GathechaPatrick EdwardsElijah OgolaGerald YongaNaftali BusakhalaEsther MunyoroJeremiah ChakayaNancy NgugiNyawira MwangiDaniel Von RegeLili-Marie WangariDavid WataRobert MakoriJulius MwangiWalter Mwandanull null
Published in: PloS one (2018)
There is substantial variation in patient costs between the public and private sectors. Most NCD diagnosis and treatment costs, even in the public sector, represent a substantial economic burden that can result in catastrophic expenditures.
Keyphrases
  • healthcare
  • health insurance
  • mental health
  • case report
  • adverse drug